

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.11910504 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.11910504 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 5.85276781 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.85276781 |
| 5 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.75545129 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 5.67896742 |
| 7 | tryptophan catabolic process (GO:0006569) | 5.26634285 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 5.26634285 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 5.26634285 |
| 10 | kynurenine metabolic process (GO:0070189) | 5.10012143 |
| 11 | intestinal cholesterol absorption (GO:0030299) | 5.09002129 |
| 12 | urea cycle (GO:0000050) | 4.98816761 |
| 13 | urea metabolic process (GO:0019627) | 4.98816761 |
| 14 | tryptophan metabolic process (GO:0006568) | 4.96987159 |
| 15 | alpha-linolenic acid metabolic process (GO:0036109) | 4.96311470 |
| 16 | high-density lipoprotein particle remodeling (GO:0034375) | 4.84170499 |
| 17 | cysteine metabolic process (GO:0006534) | 4.83244137 |
| 18 | bile acid biosynthetic process (GO:0006699) | 4.75897560 |
| 19 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.72956212 |
| 20 | lipoprotein transport (GO:0042953) | 4.70576846 |
| 21 | regulation of triglyceride catabolic process (GO:0010896) | 4.63738741 |
| 22 | phospholipid efflux (GO:0033700) | 4.61673781 |
| 23 | negative regulation of sterol transport (GO:0032372) | 4.61044286 |
| 24 | negative regulation of cholesterol transport (GO:0032375) | 4.61044286 |
| 25 | drug catabolic process (GO:0042737) | 4.60712629 |
| 26 | nitrogen cycle metabolic process (GO:0071941) | 4.55522448 |
| 27 | regulation of cholesterol esterification (GO:0010872) | 4.54398199 |
| 28 | sulfur amino acid catabolic process (GO:0000098) | 4.54298791 |
| 29 | epoxygenase P450 pathway (GO:0019373) | 4.53550149 |
| 30 | glyoxylate metabolic process (GO:0046487) | 4.52550029 |
| 31 | homocysteine metabolic process (GO:0050667) | 4.48371932 |
| 32 | bile acid metabolic process (GO:0008206) | 4.34900388 |
| 33 | intestinal absorption (GO:0050892) | 4.33090021 |
| 34 | reverse cholesterol transport (GO:0043691) | 4.32128073 |
| 35 | bile acid and bile salt transport (GO:0015721) | 4.30141389 |
| 36 | negative regulation of fibrinolysis (GO:0051918) | 4.28623632 |
| 37 | complement activation, alternative pathway (GO:0006957) | 4.27370918 |
| 38 | regulation of protein activation cascade (GO:2000257) | 4.21761897 |
| 39 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.16696397 |
| 40 | protein carboxylation (GO:0018214) | 4.16696397 |
| 41 | plasma lipoprotein particle remodeling (GO:0034369) | 4.14617123 |
| 42 | protein-lipid complex remodeling (GO:0034368) | 4.14617123 |
| 43 | macromolecular complex remodeling (GO:0034367) | 4.14617123 |
| 44 | lysine metabolic process (GO:0006553) | 4.14433785 |
| 45 | lysine catabolic process (GO:0006554) | 4.14433785 |
| 46 | serine family amino acid catabolic process (GO:0009071) | 4.07168765 |
| 47 | cholesterol efflux (GO:0033344) | 4.06899478 |
| 48 | regulation of fibrinolysis (GO:0051917) | 4.05945190 |
| 49 | plasma lipoprotein particle assembly (GO:0034377) | 4.03668767 |
| 50 | aromatic amino acid family metabolic process (GO:0009072) | 4.01842096 |
| 51 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.00968371 |
| 52 | regulation of bile acid biosynthetic process (GO:0070857) | 3.96966863 |
| 53 | regulation of complement activation (GO:0030449) | 3.96414037 |
| 54 | angiotensin maturation (GO:0002003) | 3.95927436 |
| 55 | acylglycerol homeostasis (GO:0055090) | 3.95792699 |
| 56 | triglyceride homeostasis (GO:0070328) | 3.95792699 |
| 57 | amino-acid betaine metabolic process (GO:0006577) | 3.92867071 |
| 58 | regulation of cholesterol homeostasis (GO:2000188) | 3.89030023 |
| 59 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.88964724 |
| 60 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.88964724 |
| 61 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.86595555 |
| 62 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.86595555 |
| 63 | glucuronate metabolic process (GO:0019585) | 3.83992468 |
| 64 | uronic acid metabolic process (GO:0006063) | 3.83992468 |
| 65 | adhesion of symbiont to host cell (GO:0044650) | 3.81069296 |
| 66 | virion attachment to host cell (GO:0019062) | 3.81069296 |
| 67 | drug transmembrane transport (GO:0006855) | 3.72156864 |
| 68 | tyrosine metabolic process (GO:0006570) | 3.70812472 |
| 69 | protein-lipid complex assembly (GO:0065005) | 3.69183195 |
| 70 | cholesterol homeostasis (GO:0042632) | 3.66731627 |
| 71 | indolalkylamine metabolic process (GO:0006586) | 3.66559018 |
| 72 | alpha-amino acid catabolic process (GO:1901606) | 3.65727253 |
| 73 | lipoprotein metabolic process (GO:0042157) | 3.65477782 |
| 74 | adhesion of symbiont to host (GO:0044406) | 3.63475170 |
| 75 | flavonoid metabolic process (GO:0009812) | 3.62357440 |
| 76 | sterol homeostasis (GO:0055092) | 3.61051136 |
| 77 | phospholipid homeostasis (GO:0055091) | 3.59941114 |
| 78 | ethanol oxidation (GO:0006069) | 3.58299654 |
| 79 | cellular glucuronidation (GO:0052695) | 3.57345367 |
| 80 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.51013340 |
| 81 | benzene-containing compound metabolic process (GO:0042537) | 3.50580005 |
| 82 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.49498393 |
| 83 | plasma lipoprotein particle clearance (GO:0034381) | 3.49295404 |
| 84 | diacylglycerol metabolic process (GO:0046339) | 3.48533851 |
| 85 | glycine metabolic process (GO:0006544) | 3.47466204 |
| 86 | urate metabolic process (GO:0046415) | 3.43184861 |
| 87 | valine metabolic process (GO:0006573) | 3.43159565 |
| 88 | drug metabolic process (GO:0017144) | 3.42439788 |
| 89 | peptide hormone processing (GO:0016486) | 3.42024723 |
| 90 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.41623177 |
| 91 | serine family amino acid metabolic process (GO:0009069) | 3.40246226 |
| 92 | cellular modified amino acid catabolic process (GO:0042219) | 3.39820041 |
| 93 | amine catabolic process (GO:0009310) | 3.39657395 |
| 94 | cellular biogenic amine catabolic process (GO:0042402) | 3.39657395 |
| 95 | cellular amino acid catabolic process (GO:0009063) | 3.38163367 |
| 96 | positive regulation of lipid catabolic process (GO:0050996) | 3.36380361 |
| 97 | glomerular visceral epithelial cell development (GO:0072015) | 3.33491456 |
| 98 | exogenous drug catabolic process (GO:0042738) | 3.33125206 |
| 99 | glutamate metabolic process (GO:0006536) | 3.32020880 |
| 100 | plasma lipoprotein particle organization (GO:0071827) | 3.30160916 |
| 101 | serine family amino acid biosynthetic process (GO:0009070) | 3.28176388 |
| 102 | cellular ketone body metabolic process (GO:0046950) | 3.27662758 |
| 103 | COPII vesicle coating (GO:0048208) | 3.26315928 |
| 104 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.26019884 |
| 105 | negative regulation of protein activation cascade (GO:2000258) | 3.24974005 |
| 106 | hormone catabolic process (GO:0042447) | 3.24392291 |
| 107 | imidazole-containing compound metabolic process (GO:0052803) | 3.23222383 |
| 108 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.21101106 |
| 109 | endocrine process (GO:0050886) | 3.21101106 |
| 110 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.21101106 |
| 111 | NADH metabolic process (GO:0006734) | 3.19381619 |
| 112 | drug transport (GO:0015893) | 3.17476438 |
| 113 | regulation of guanylate cyclase activity (GO:0031282) | 3.17425204 |
| 114 | short-chain fatty acid metabolic process (GO:0046459) | 3.17316569 |
| 115 | protein-lipid complex subunit organization (GO:0071825) | 3.14879478 |
| 116 | regulation of plasminogen activation (GO:0010755) | 3.14324673 |
| 117 | arginine metabolic process (GO:0006525) | 3.12554003 |
| 118 | low-density lipoprotein particle remodeling (GO:0034374) | 3.11864369 |
| 119 | sphingomyelin metabolic process (GO:0006684) | 3.10219642 |
| 120 | oligosaccharide catabolic process (GO:0009313) | 3.08486939 |
| 121 | peptide catabolic process (GO:0043171) | 3.06717383 |
| 122 | negative regulation of complement activation (GO:0045916) | 2.99218291 |
| 123 | glycosphingolipid catabolic process (GO:0046479) | 2.90257583 |
| 124 | fructose metabolic process (GO:0006000) | 2.86681749 |
| 125 | negative regulation of hemostasis (GO:1900047) | 2.81209156 |
| 126 | negative regulation of blood coagulation (GO:0030195) | 2.81209156 |
| 127 | negative regulation of fatty acid transport (GO:2000192) | 2.80030464 |
| 128 | glycolipid catabolic process (GO:0019377) | 2.78019413 |
| 129 | negative regulation of coagulation (GO:0050819) | 2.77476403 |
| 130 | * regulation of extracellular matrix disassembly (GO:0010715) | 2.76968365 |
| 131 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.76853196 |
| 132 | cellular zinc ion homeostasis (GO:0006882) | 2.73320232 |
| 133 | positive regulation of extracellular matrix organization (GO:1903055) | 2.71215796 |
| 134 | macroautophagy (GO:0016236) | 2.69006657 |
| 135 | negative regulation of wound healing (GO:0061045) | 2.66472665 |
| 136 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.65322181 |
| 137 | regulation of systemic arterial blood pressure (GO:0003073) | 2.65002536 |
| 138 | fibrinolysis (GO:0042730) | 2.62477490 |
| 139 | skin morphogenesis (GO:0043589) | 2.60285993 |
| 140 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.59388034 |
| 141 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.57349259 |
| 142 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.56752125 |
| 143 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.55545353 |
| 144 | cell adhesion mediated by integrin (GO:0033627) | 2.52063921 |
| 145 | regulation of cholesterol metabolic process (GO:0090181) | 2.46885918 |
| 146 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.46609327 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.20827135 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.61692984 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.04321878 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.61921296 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.27558178 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.14573814 |
| 7 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.89256131 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.73678602 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.71812164 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.28918455 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.25849504 |
| 12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.06082113 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.82978961 |
| 14 | GATA1_22025678_ChIP-Seq_K562_Human | 2.60388246 |
| 15 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.41510943 |
| 16 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.33692167 |
| 17 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.29697518 |
| 18 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.26596324 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.19754734 |
| 20 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.13884809 |
| 21 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.97117990 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.87439029 |
| 23 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.84093135 |
| 24 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.81741464 |
| 25 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.81173898 |
| 26 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.80047673 |
| 27 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.71883739 |
| 28 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.65147384 |
| 29 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.64945062 |
| 30 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.62001639 |
| 31 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.57920717 |
| 32 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.56783389 |
| 33 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.54425067 |
| 34 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.51910407 |
| 35 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.47272241 |
| 36 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.45294220 |
| 37 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.36702126 |
| 38 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.35695489 |
| 39 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.35385034 |
| 40 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.34145361 |
| 41 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.33511669 |
| 42 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.32451365 |
| 43 | MYC_22102868_ChIP-Seq_BL_Human | 1.31889915 |
| 44 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.30093376 |
| 45 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.28638289 |
| 46 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.25530982 |
| 47 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.22377528 |
| 48 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.20263577 |
| 49 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.20237765 |
| 50 | * TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.19355083 |
| 51 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.19158068 |
| 52 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.18703367 |
| 53 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.17181256 |
| 54 | MYB_26560356_Chip-Seq_TH1_Human | 1.16861371 |
| 55 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.15758725 |
| 56 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.15709397 |
| 57 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.14640680 |
| 58 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.13868418 |
| 59 | MAF_26560356_Chip-Seq_TH1_Human | 1.13827343 |
| 60 | MYB_26560356_Chip-Seq_TH2_Human | 1.13563133 |
| 61 | TP53_16413492_ChIP-PET_HCT116_Human | 1.13348750 |
| 62 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.12500774 |
| 63 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.12210831 |
| 64 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11915557 |
| 65 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.11879759 |
| 66 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.10648340 |
| 67 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.10648340 |
| 68 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.10469905 |
| 69 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.10438319 |
| 70 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.08421434 |
| 71 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.08320807 |
| 72 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08289131 |
| 73 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.07925272 |
| 74 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07494908 |
| 75 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.03677262 |
| 76 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.02111474 |
| 77 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.01466626 |
| 78 | UTX_26944678_Chip-Seq_JUKART_Human | 1.01203108 |
| 79 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.01071087 |
| 80 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01027651 |
| 81 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.01006994 |
| 82 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.00308080 |
| 83 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.00308080 |
| 84 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.00170853 |
| 85 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.98334773 |
| 86 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.98222092 |
| 87 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.97204777 |
| 88 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.96401419 |
| 89 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.95410412 |
| 90 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93146355 |
| 91 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.91642646 |
| 92 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.91251859 |
| 93 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.89592392 |
| 94 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.88465084 |
| 95 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.88459268 |
| 96 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.88337017 |
| 97 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.88103446 |
| 98 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.87810009 |
| 99 | GATA2_19941826_ChIP-Seq_K562_Human | 0.87059946 |
| 100 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.86042760 |
| 101 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85683787 |
| 102 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.84461715 |
| 103 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.84226919 |
| 104 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.84045660 |
| 105 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.83283229 |
| 106 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.83271469 |
| 107 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 0.81897888 |
| 108 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.81759507 |
| 109 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.80967319 |
| 110 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.80496159 |
| 111 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.79359731 |
| 112 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.79211979 |
| 113 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.78980330 |
| 114 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.78839306 |
| 115 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.78735836 |
| 116 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.78234135 |
| 117 | GATA1_19941826_ChIP-Seq_K562_Human | 0.77666863 |
| 118 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.77593715 |
| 119 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.77548189 |
| 120 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.76695282 |
| 121 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76639997 |
| 122 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.75465190 |
| 123 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.75455557 |
| 124 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.75439222 |
| 125 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.73653506 |
| 126 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.72386901 |
| 127 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.71284931 |
| 128 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.70647465 |
| 129 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.70344828 |
| 130 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.69758264 |
| 131 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.69503884 |
| 132 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.69252618 |
| 133 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.68327009 |
| 134 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.67142482 |
| 135 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.67138766 |
| 136 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.66893670 |
| 137 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.66780529 |
| 138 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.65608492 |
| 139 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.64144926 |
| 140 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.63905318 |
| 141 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.63838531 |
| 142 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.62534224 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.52851076 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 6.65358357 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.18535250 |
| 4 | MP0005365_abnormal_bile_salt | 4.95606340 |
| 5 | MP0008438_abnormal_cutaneous_collagen | 4.15509208 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.11242910 |
| 7 | MP0003252_abnormal_bile_duct | 3.75156260 |
| 8 | MP0001666_abnormal_nutrient_absorption | 3.26194288 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 3.05279436 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.03358728 |
| 11 | MP0009840_abnormal_foam_cell | 2.98981822 |
| 12 | MP0002138_abnormal_hepatobiliary_system | 2.54793256 |
| 13 | MP0005332_abnormal_amino_acid | 2.49379854 |
| 14 | MP0004272_abnormal_basement_membrane | 2.28266171 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.07299714 |
| 16 | MP0003195_calcinosis | 2.00466322 |
| 17 | MP0000609_abnormal_liver_physiology | 1.99718853 |
| 18 | MP0004019_abnormal_vitamin_homeostasis | 1.99507526 |
| 19 | MP0005083_abnormal_biliary_tract | 1.94986719 |
| 20 | MP0009643_abnormal_urine_homeostasis | 1.81690691 |
| 21 | MP0001958_emphysema | 1.79179894 |
| 22 | MP0005275_abnormal_skin_tensile | 1.77677357 |
| 23 | MP0002118_abnormal_lipid_homeostasis | 1.72165724 |
| 24 | MP0005503_abnormal_tendon_morphology | 1.69115257 |
| 25 | MP0005058_abnormal_lysosome_morphology | 1.62647990 |
| 26 | MP0009384_cardiac_valve_regurgitation | 1.62038532 |
| 27 | MP0005257_abnormal_intraocular_pressure | 1.60185292 |
| 28 | MP0005319_abnormal_enzyme/_coenzyme | 1.58874069 |
| 29 | MP0003868_abnormal_feces_composition | 1.51795985 |
| 30 | MP0003300_gastrointestinal_ulcer | 1.50223977 |
| 31 | MP0005023_abnormal_wound_healing | 1.44345984 |
| 32 | MP0009780_abnormal_chondrocyte_physiolo | 1.39755903 |
| 33 | MP0001764_abnormal_homeostasis | 1.37638155 |
| 34 | MP0003950_abnormal_plasma_membrane | 1.35748865 |
| 35 | MP0010234_abnormal_vibrissa_follicle | 1.34306683 |
| 36 | MP0002166_altered_tumor_susceptibility | 1.33011874 |
| 37 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.29643975 |
| 38 | MP0004264_abnormal_extraembryonic_tissu | 1.29593319 |
| 39 | MP0002933_joint_inflammation | 1.28538429 |
| 40 | MP0001835_abnormal_antigen_presentation | 1.25399570 |
| 41 | MP0003279_aneurysm | 1.25084219 |
| 42 | MP0003183_abnormal_peptide_metabolism | 1.22546407 |
| 43 | MP0005409_darkened_coat_color | 1.21186576 |
| 44 | MP0002896_abnormal_bone_mineralization | 1.21021813 |
| 45 | MP0000685_abnormal_immune_system | 1.20014881 |
| 46 | MP0002998_abnormal_bone_remodeling | 1.18452499 |
| 47 | MP0002136_abnormal_kidney_physiology | 1.17220001 |
| 48 | MP0008469_abnormal_protein_level | 1.14336876 |
| 49 | MP0010368_abnormal_lymphatic_system | 1.13554522 |
| 50 | MP0000598_abnormal_liver_morphology | 1.13496866 |
| 51 | MP0001533_abnormal_skeleton_physiology | 1.13250304 |
| 52 | MP0009697_abnormal_copulation | 1.12244209 |
| 53 | MP0005164_abnormal_response_to | 1.10385431 |
| 54 | MP0003172_abnormal_lysosome_physiology | 1.08115711 |
| 55 | MP0005084_abnormal_gallbladder_morpholo | 1.07495254 |
| 56 | MP0005451_abnormal_body_composition | 1.07383058 |
| 57 | MP0009764_decreased_sensitivity_to | 1.06796742 |
| 58 | MP0001664_abnormal_digestion | 1.05794517 |
| 59 | MP0005636_abnormal_mineral_homeostasis | 1.05498294 |
| 60 | MP0003436_decreased_susceptibility_to | 1.05284860 |
| 61 | MP0000538_abnormal_urinary_bladder | 1.03777283 |
| 62 | MP0010155_abnormal_intestine_physiology | 1.03053921 |
| 63 | MP0001542_abnormal_bone_strength | 1.01546365 |
| 64 | MP0005464_abnormal_platelet_physiology | 1.00054022 |
| 65 | MP0004147_increased_porphyrin_level | 0.99536123 |
| 66 | MP0000013_abnormal_adipose_tissue | 0.99007605 |
| 67 | MP0001800_abnormal_humoral_immune | 0.98575844 |
| 68 | MP0001873_stomach_inflammation | 0.97431260 |
| 69 | MP0004947_skin_inflammation | 0.97220585 |
| 70 | MP0001756_abnormal_urination | 0.96908905 |
| 71 | MP0005220_abnormal_exocrine_pancreas | 0.94364379 |
| 72 | MP0003705_abnormal_hypodermis_morpholog | 0.94287229 |
| 73 | MP0002876_abnormal_thyroid_physiology | 0.92362414 |
| 74 | MP0001790_abnormal_immune_system | 0.91179508 |
| 75 | MP0005387_immune_system_phenotype | 0.91179508 |
| 76 | * MP0009642_abnormal_blood_homeostasis | 0.90373345 |
| 77 | MP0003091_abnormal_cell_migration | 0.89626213 |
| 78 | MP0002254_reproductive_system_inflammat | 0.89259645 |
| 79 | MP0001661_extended_life_span | 0.89017356 |
| 80 | MP0001845_abnormal_inflammatory_respons | 0.88383661 |
| 81 | MP0009785_altered_susceptibility_to | 0.87872482 |
| 82 | MP0010386_abnormal_urinary_bladder | 0.87182776 |
| 83 | MP0003866_abnormal_defecation | 0.86416919 |
| 84 | MP0009763_increased_sensitivity_to | 0.86330123 |
| 85 | MP0003566_abnormal_cell_adhesion | 0.84194120 |
| 86 | MP0003186_abnormal_redox_activity | 0.83021317 |
| 87 | MP0003879_abnormal_hair_cell | 0.82991046 |
| 88 | MP0005671_abnormal_response_to | 0.82371386 |
| 89 | MP0002089_abnormal_postnatal_growth/wei | 0.80198970 |
| 90 | MP0009765_abnormal_xenobiotic_induced | 0.79431177 |
| 91 | MP0003724_increased_susceptibility_to | 0.79105942 |
| 92 | MP0003763_abnormal_thymus_physiology | 0.79053688 |
| 93 | MP0003656_abnormal_erythrocyte_physiolo | 0.78189397 |
| 94 | MP0002006_tumorigenesis | 0.77998519 |
| 95 | MP0005025_abnormal_response_to | 0.77328896 |
| 96 | * MP0002078_abnormal_glucose_homeostasis | 0.76980713 |
| 97 | MP0004043_abnormal_pH_regulation | 0.76507939 |
| 98 | MP0005408_hypopigmentation | 0.76253714 |
| 99 | MP0004858_abnormal_nervous_system | 0.74954183 |
| 100 | MP0004782_abnormal_surfactant_physiolog | 0.74446458 |
| 101 | MP0002168_other_aberrant_phenotype | 0.73975096 |
| 102 | MP0005647_abnormal_sex_gland | 0.73549330 |
| 103 | MP0002295_abnormal_pulmonary_circulatio | 0.73365916 |
| 104 | MP0000249_abnormal_blood_vessel | 0.73078025 |
| 105 | MP0002723_abnormal_immune_serum | 0.72108917 |
| 106 | MP0002060_abnormal_skin_morphology | 0.70585016 |
| 107 | MP0003045_fibrosis | 0.69952062 |
| 108 | MP0001765_abnormal_ion_homeostasis | 0.69027044 |
| 109 | MP0003941_abnormal_skin_development | 0.68894369 |
| 110 | MP0002971_abnormal_brown_adipose | 0.68751157 |
| 111 | MP0000604_amyloidosis | 0.68219825 |
| 112 | MP0002928_abnormal_bile_duct | 0.68104955 |
| 113 | MP0002452_abnormal_antigen_presenting | 0.68033644 |
| 114 | MP0005165_increased_susceptibility_to | 0.66028049 |
| 115 | MP0005390_skeleton_phenotype | 0.65779445 |
| 116 | MP0004883_abnormal_blood_vessel | 0.65664386 |
| 117 | MP0000858_altered_metastatic_potential | 0.65012675 |
| 118 | MP0008004_abnormal_stomach_pH | 0.64789302 |
| 119 | MP0009333_abnormal_splenocyte_physiolog | 0.64719686 |
| 120 | MP0002135_abnormal_kidney_morphology | 0.63118647 |
| 121 | MP0010352_gastrointestinal_tract_polyps | 0.62752011 |
| 122 | MP0005334_abnormal_fat_pad | 0.61938720 |
| 123 | MP0000689_abnormal_spleen_morphology | 0.61418805 |
| 124 | MP0006054_spinal_hemorrhage | 0.61209932 |
| 125 | MP0000716_abnormal_immune_system | 0.60937620 |
| 126 | MP0001819_abnormal_immune_cell | 0.59106579 |
| 127 | MP0002420_abnormal_adaptive_immunity | 0.59076116 |
| 128 | MP0000477_abnormal_intestine_morphology | 0.58906125 |
| 129 | MP0005448_abnormal_energy_balance | 0.57855094 |
| 130 | MP0002419_abnormal_innate_immunity | 0.57551210 |
| 131 | MP0005000_abnormal_immune_tolerance | 0.57459667 |
| 132 | MP0001944_abnormal_pancreas_morphology | 0.57231285 |
| 133 | MP0008961_abnormal_basal_metabolism | 0.55760278 |
| 134 | MP0002398_abnormal_bone_marrow | 0.54255300 |
| 135 | MP0002722_abnormal_immune_system | 0.53901531 |
| 136 | MP0005376_homeostasis/metabolism_phenot | 0.53833490 |
| 137 | MP0000230_abnormal_systemic_arterial | 0.52419066 |
| 138 | MP0006082_CNS_inflammation | 0.51686407 |
| 139 | MP0001879_abnormal_lymphatic_vessel | 0.51667895 |
| 140 | MP0003638_abnormal_response/metabolism_ | 0.51438598 |
| 141 | MP0002429_abnormal_blood_cell | 0.51274829 |
| 142 | MP0001853_heart_inflammation | 0.51041490 |
| 143 | MP0005166_decreased_susceptibility_to | 0.50889930 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypobetalipoproteinemia (HP:0003563) | 5.86662567 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.84366049 |
| 3 | Deep venous thrombosis (HP:0002625) | 5.80208480 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.77653164 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.52426998 |
| 6 | Xanthomatosis (HP:0000991) | 4.99687053 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 4.76284911 |
| 8 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.68206100 |
| 9 | Protrusio acetabuli (HP:0003179) | 4.21065120 |
| 10 | Conjugated hyperbilirubinemia (HP:0002908) | 4.14206170 |
| 11 | Fat malabsorption (HP:0002630) | 3.97937880 |
| 12 | Hypolipoproteinemia (HP:0010981) | 3.86966399 |
| 13 | Hyperlipoproteinemia (HP:0010980) | 3.83513221 |
| 14 | Complement deficiency (HP:0004431) | 3.82097352 |
| 15 | Hypoglycemic coma (HP:0001325) | 3.80884640 |
| 16 | Hyperglycinuria (HP:0003108) | 3.68060532 |
| 17 | Abnormality of the common coagulation pathway (HP:0010990) | 3.67899794 |
| 18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.64160178 |
| 19 | Epidermoid cyst (HP:0200040) | 3.60594139 |
| 20 | Hyperammonemia (HP:0001987) | 3.60203951 |
| 21 | Joint hemorrhage (HP:0005261) | 3.51885200 |
| 22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.50329901 |
| 23 | Ketosis (HP:0001946) | 3.49826578 |
| 24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.39536525 |
| 25 | Premature rupture of membranes (HP:0001788) | 3.34988361 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.32242938 |
| 27 | Abnormality of glycine metabolism (HP:0010895) | 3.32242938 |
| 28 | Abnormality of the intrinsic pathway (HP:0010989) | 3.25085215 |
| 29 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.23411966 |
| 30 | Acanthocytosis (HP:0001927) | 3.23293338 |
| 31 | Aortic dissection (HP:0002647) | 3.21679324 |
| 32 | Hyperglycinemia (HP:0002154) | 3.16005587 |
| 33 | Aortic aneurysm (HP:0004942) | 3.09691846 |
| 34 | Hypercholesterolemia (HP:0003124) | 3.03305922 |
| 35 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.95673538 |
| 36 | Abnormality of nucleobase metabolism (HP:0010932) | 2.95507270 |
| 37 | Abnormality of purine metabolism (HP:0004352) | 2.95424136 |
| 38 | Hyperbilirubinemia (HP:0002904) | 2.94555777 |
| 39 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.94058265 |
| 40 | Thin bony cortex (HP:0002753) | 2.90662602 |
| 41 | Vertebral compression fractures (HP:0002953) | 2.90642857 |
| 42 | Ketoacidosis (HP:0001993) | 2.90130980 |
| 43 | Autoimmune thrombocytopenia (HP:0001973) | 2.87975107 |
| 44 | Abnormality of complement system (HP:0005339) | 2.82134782 |
| 45 | Glomerulonephritis (HP:0000099) | 2.79141187 |
| 46 | Vascular tortuosity (HP:0004948) | 2.79011062 |
| 47 | Abnormality of methionine metabolism (HP:0010901) | 2.77263667 |
| 48 | Hypophosphatemic rickets (HP:0004912) | 2.76756257 |
| 49 | Abnormality of proline metabolism (HP:0010907) | 2.73916517 |
| 50 | Hydroxyprolinuria (HP:0003080) | 2.73916517 |
| 51 | Focal segmental glomerulosclerosis (HP:0000097) | 2.72518854 |
| 52 | Hypoalphalipoproteinemia (HP:0003233) | 2.70922008 |
| 53 | Mucopolysacchariduria (HP:0008155) | 2.70345467 |
| 54 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.70345467 |
| 55 | Hypoglycemic seizures (HP:0002173) | 2.68989265 |
| 56 | Mesangial abnormality (HP:0001966) | 2.68477030 |
| 57 | Widely patent fontanelles and sutures (HP:0004492) | 2.67796747 |
| 58 | Peritonitis (HP:0002586) | 2.64623501 |
| 59 | Malnutrition (HP:0004395) | 2.60051650 |
| 60 | Nephritis (HP:0000123) | 2.59839789 |
| 61 | Cervical subluxation (HP:0003308) | 2.59103303 |
| 62 | Myocardial infarction (HP:0001658) | 2.57424781 |
| 63 | Steatorrhea (HP:0002570) | 2.55267013 |
| 64 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.54956007 |
| 65 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.54956007 |
| 66 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.54956007 |
| 67 | Gout (HP:0001997) | 2.54237731 |
| 68 | Late onset (HP:0003584) | 2.53837783 |
| 69 | Proximal tubulopathy (HP:0000114) | 2.52781259 |
| 70 | Wormian bones (HP:0002645) | 2.46154187 |
| 71 | Arterial tortuosity (HP:0005116) | 2.45841670 |
| 72 | Dysostosis multiplex (HP:0000943) | 2.45549758 |
| 73 | Hypophosphatemia (HP:0002148) | 2.41855692 |
| 74 | Glomerulosclerosis (HP:0000096) | 2.41789949 |
| 75 | Metabolic acidosis (HP:0001942) | 2.39719158 |
| 76 | Abnormality of carpal bone ossification (HP:0006257) | 2.39286755 |
| 77 | Hepatocellular carcinoma (HP:0001402) | 2.38886060 |
| 78 | Vacuolated lymphocytes (HP:0001922) | 2.38663382 |
| 79 | Abnormality of vitamin metabolism (HP:0100508) | 2.37551845 |
| 80 | Ovoid vertebral bodies (HP:0003300) | 2.36002509 |
| 81 | Pigmentary retinal degeneration (HP:0001146) | 2.34211381 |
| 82 | Delayed CNS myelination (HP:0002188) | 2.34159212 |
| 83 | Esophageal varix (HP:0002040) | 2.34044113 |
| 84 | Rickets (HP:0002748) | 2.32798894 |
| 85 | Mitral stenosis (HP:0001718) | 2.32388528 |
| 86 | Potter facies (HP:0002009) | 2.30617851 |
| 87 | Facial shape deformation (HP:0011334) | 2.30617851 |
| 88 | Hypoplasia of the thymus (HP:0000778) | 2.29463530 |
| 89 | Flat acetabular roof (HP:0003180) | 2.26856625 |
| 90 | Abnormality of vitamin B metabolism (HP:0004340) | 2.25556017 |
| 91 | Ileus (HP:0002595) | 2.23877071 |
| 92 | Polycythemia (HP:0001901) | 2.20157298 |
| 93 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.19017962 |
| 94 | Generalized aminoaciduria (HP:0002909) | 2.15935308 |
| 95 | Neonatal short-limb short stature (HP:0008921) | 2.15766966 |
| 96 | Vascular calcification (HP:0004934) | 2.14961626 |
| 97 | Metaphyseal irregularity (HP:0003025) | 2.14089443 |
| 98 | Gingival bleeding (HP:0000225) | 2.13053780 |
| 99 | Abnormality of urine glucose concentration (HP:0011016) | 2.12979815 |
| 100 | Skin nodule (HP:0200036) | 2.12909324 |
| 101 | Follicular hyperkeratosis (HP:0007502) | 2.12062517 |
| 102 | Protuberant abdomen (HP:0001538) | 2.11953035 |
| 103 | Hypochromic microcytic anemia (HP:0004840) | 2.11170875 |
| 104 | Femoral bowing (HP:0002980) | 2.09805506 |
| 105 | Pancreatitis (HP:0001733) | 2.08924395 |
| 106 | Spondylolisthesis (HP:0003302) | 2.08575310 |
| 107 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.08425745 |
| 108 | Abnormality of glycolipid metabolism (HP:0010969) | 2.08425745 |
| 109 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.08425745 |
| 110 | Thrombophlebitis (HP:0004418) | 2.07582075 |
| 111 | Flared iliac wings (HP:0002869) | 2.07496140 |
| 112 | T lymphocytopenia (HP:0005403) | 2.07322330 |
| 113 | Poikilocytosis (HP:0004447) | 2.07238685 |
| 114 | Symptomatic seizures (HP:0011145) | 2.06765133 |
| 115 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.04794157 |
| 116 | Osteolytic defects of the hand bones (HP:0009699) | 2.04794157 |
| 117 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.04364756 |
| 118 | Wide cranial sutures (HP:0010537) | 2.02990355 |
| 119 | Enlarged epiphyses (HP:0010580) | 2.02270124 |
| 120 | Abnormality of T cell number (HP:0011839) | 2.00640763 |
| 121 | Recurrent viral infections (HP:0004429) | 2.00188732 |
| 122 | Dicarboxylic aciduria (HP:0003215) | 2.00039962 |
| 123 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.00039962 |
| 124 | Soft skin (HP:0000977) | 1.99485193 |
| 125 | Abnormality of the acetabulum (HP:0003170) | 1.99364742 |
| 126 | Spastic diplegia (HP:0001264) | 1.98754811 |
| 127 | Osteomalacia (HP:0002749) | 1.97440247 |
| 128 | Cupped ribs (HP:0000887) | 1.97205637 |
| 129 | Spontaneous abortion (HP:0005268) | 1.96785891 |
| 130 | Abnormality of serum amino acid levels (HP:0003112) | 1.96725928 |
| 131 | Ankle contracture (HP:0006466) | 1.95926670 |
| 132 | Abdominal distention (HP:0003270) | 1.94759777 |
| 133 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.93406309 |
| 134 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.93406309 |
| 135 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.93172519 |
| 136 | Sensorimotor neuropathy (HP:0007141) | 1.93163736 |
| 137 | Systemic lupus erythematosus (HP:0002725) | 1.92687646 |
| 138 | Irritability (HP:0000737) | 1.92401292 |
| 139 | Alkalosis (HP:0001948) | 1.91478677 |
| 140 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.91157127 |
| 141 | Abnormal tarsal ossification (HP:0008369) | 1.90272650 |
| 142 | Chronic diarrhea (HP:0002028) | 1.90042255 |
| 143 | Abnormality of B cell number (HP:0010975) | 1.89707444 |
| 144 | B lymphocytopenia (HP:0010976) | 1.89707444 |
| 145 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.89622469 |
| 146 | Hypoalbuminemia (HP:0003073) | 1.88223566 |
| 147 | Abnormal albumin level (HP:0012116) | 1.88223566 |
| 148 | Spontaneous hematomas (HP:0007420) | 1.88064232 |
| 149 | Joint swelling (HP:0001386) | 1.87252231 |
| 150 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.86895464 |
| 151 | Abnormal hand bone ossification (HP:0010660) | 1.86444454 |
| 152 | Aneurysm (HP:0002617) | 1.86254783 |
| 153 | Abnormal ossification of hand bones (HP:0005921) | 1.85160833 |
| 154 | Increased mean platelet volume (HP:0011877) | 1.85127100 |
| 155 | Cardiovascular calcification (HP:0011915) | 1.84946647 |
| 156 | Autoimmune hemolytic anemia (HP:0001890) | 1.84890945 |
| 157 | Abnormal platelet volume (HP:0011876) | 1.83994224 |
| 158 | Abnormal glucose tolerance (HP:0001952) | 1.83969857 |
| 159 | Nephrolithiasis (HP:0000787) | 1.83728038 |
| 160 | Hemorrhage of the eye (HP:0011885) | 1.83478568 |
| 161 | Glycosuria (HP:0003076) | 1.81902765 |
| 162 | Hypotension (HP:0002615) | 1.81354959 |
| 163 | Dilatation of the ascending aorta (HP:0005111) | 1.81295011 |
| 164 | Osteoarthritis (HP:0002758) | 1.80296641 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.85704625 |
| 2 | FGFR4 | 3.72022019 |
| 3 | MAP3K10 | 3.33650009 |
| 4 | FRK | 3.30005356 |
| 5 | ACVR1B | 3.26854373 |
| 6 | BCKDK | 3.03343714 |
| 7 | TAOK3 | 2.92158498 |
| 8 | MAP4K1 | 2.88827345 |
| 9 | PDGFRA | 2.60342359 |
| 10 | GRK6 | 2.59064934 |
| 11 | MST4 | 2.55178934 |
| 12 | TYK2 | 2.51171628 |
| 13 | SIK1 | 2.47222529 |
| 14 | DDR2 | 2.40506317 |
| 15 | FLT3 | 2.12502776 |
| 16 | MAP3K12 | 2.09581264 |
| 17 | PKN2 | 2.06931221 |
| 18 | PTK6 | 1.78278255 |
| 19 | EEF2K | 1.71173617 |
| 20 | STK10 | 1.67629392 |
| 21 | INSRR | 1.61563852 |
| 22 | MAPK11 | 1.60017149 |
| 23 | JAK3 | 1.58934844 |
| 24 | JAK1 | 1.58532251 |
| 25 | MAP3K14 | 1.54198360 |
| 26 | TBK1 | 1.51590475 |
| 27 | ZAP70 | 1.48393469 |
| 28 | MST1R | 1.43610847 |
| 29 | LRRK2 | 1.42177808 |
| 30 | KDR | 1.41383068 |
| 31 | TRIB3 | 1.41054831 |
| 32 | FGFR3 | 1.39361213 |
| 33 | CDC42BPA | 1.39259541 |
| 34 | PIK3CA | 1.36997149 |
| 35 | MAP3K7 | 1.33167893 |
| 36 | MET | 1.30881425 |
| 37 | IKBKE | 1.28967407 |
| 38 | ITK | 1.28765727 |
| 39 | NLK | 1.27702150 |
| 40 | CSK | 1.25293302 |
| 41 | EPHB1 | 1.20842907 |
| 42 | BTK | 1.17260712 |
| 43 | AKT3 | 1.16726066 |
| 44 | TGFBR2 | 1.15292913 |
| 45 | CSF1R | 1.14808400 |
| 46 | FGFR2 | 1.14084330 |
| 47 | JAK2 | 1.12085420 |
| 48 | STK39 | 1.11732445 |
| 49 | TRPM7 | 1.11555713 |
| 50 | STK38 | 1.09662153 |
| 51 | PDGFRB | 1.09416650 |
| 52 | PTK2 | 1.08216565 |
| 53 | MAP3K13 | 1.07767183 |
| 54 | PIK3CG | 1.02024017 |
| 55 | WNK4 | 0.99980431 |
| 56 | WNK1 | 0.94871079 |
| 57 | ICK | 0.91468595 |
| 58 | PDPK1 | 0.90541006 |
| 59 | NEK9 | 0.89496087 |
| 60 | DYRK1B | 0.86869458 |
| 61 | IRAK3 | 0.86047469 |
| 62 | RIPK1 | 0.85603643 |
| 63 | PRKAA2 | 0.83968212 |
| 64 | SYK | 0.81914420 |
| 65 | TXK | 0.81539350 |
| 66 | NUAK1 | 0.81428835 |
| 67 | TIE1 | 0.79752273 |
| 68 | CHUK | 0.76905681 |
| 69 | TGFBR1 | 0.76772221 |
| 70 | MAP2K3 | 0.76061649 |
| 71 | MYLK | 0.75929040 |
| 72 | TESK1 | 0.72699706 |
| 73 | MAPK15 | 0.71888530 |
| 74 | PRKD2 | 0.70931464 |
| 75 | TEC | 0.70622140 |
| 76 | BLK | 0.68786434 |
| 77 | LATS1 | 0.68779421 |
| 78 | PRPF4B | 0.68098411 |
| 79 | FGFR1 | 0.67833516 |
| 80 | MAP3K1 | 0.67365430 |
| 81 | PAK2 | 0.67329737 |
| 82 | RET | 0.67263901 |
| 83 | MAPK4 | 0.65846480 |
| 84 | CDK6 | 0.65278073 |
| 85 | KIT | 0.65135660 |
| 86 | PAK4 | 0.64900557 |
| 87 | MAP3K3 | 0.63123998 |
| 88 | PRKCQ | 0.63121610 |
| 89 | IKBKB | 0.62921388 |
| 90 | PRKG2 | 0.62804348 |
| 91 | EPHA3 | 0.61119453 |
| 92 | CDK4 | 0.60270225 |
| 93 | STK24 | 0.60095314 |
| 94 | MELK | 0.57516273 |
| 95 | LCK | 0.57387465 |
| 96 | PIM1 | 0.57258720 |
| 97 | MAP3K2 | 0.55871801 |
| 98 | SCYL2 | 0.55718194 |
| 99 | SGK3 | 0.54829006 |
| 100 | ERBB4 | 0.54067708 |
| 101 | FER | 0.54032080 |
| 102 | HIPK2 | 0.51737333 |
| 103 | WNK3 | 0.51092724 |
| 104 | ADRBK2 | 0.50835276 |
| 105 | EPHA2 | 0.50226817 |
| 106 | STK4 | 0.49964793 |
| 107 | PASK | 0.49780184 |
| 108 | MAPK7 | 0.49618811 |
| 109 | SRC | 0.49558234 |
| 110 | TESK2 | 0.47018896 |
| 111 | BCR | 0.46449721 |
| 112 | MAP3K8 | 0.45797103 |
| 113 | MATK | 0.45455342 |
| 114 | PDK1 | 0.45133140 |
| 115 | IGF1R | 0.44932420 |
| 116 | PRKACG | 0.44467822 |
| 117 | TYRO3 | 0.43877076 |
| 118 | NTRK1 | 0.42805397 |
| 119 | CAMKK2 | 0.42106775 |
| 120 | MAP2K2 | 0.41655853 |
| 121 | MAPKAPK2 | 0.41593806 |
| 122 | GRK7 | 0.41480327 |
| 123 | LYN | 0.41124372 |
| 124 | BMPR2 | 0.39469735 |
| 125 | PRKAA1 | 0.38366807 |
| 126 | PDK2 | 0.38075910 |
| 127 | RPS6KA4 | 0.36982812 |
| 128 | GSK3A | 0.36817038 |
| 129 | MAP2K6 | 0.36719745 |
| 130 | PRKCH | 0.35760128 |
| 131 | GRK1 | 0.35728875 |
| 132 | ERBB2 | 0.35682736 |
| 133 | RPS6KB2 | 0.35387690 |
| 134 | LMTK2 | 0.33486006 |
| 135 | MAPKAPK3 | 0.32267964 |
| 136 | CDK12 | 0.32071403 |
| 137 | CAMK1D | 0.31904902 |
| 138 | MAPK12 | 0.31238634 |
| 139 | MTOR | 0.29738360 |
| 140 | STK3 | 0.28758375 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.00074893 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.50939298 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.21229150 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.84154147 |
| 5 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.82071099 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.75709617 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47191892 |
| 8 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.39074167 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.31620832 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.29174280 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.24921077 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.21403045 |
| 13 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.13187246 |
| 14 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.12522033 |
| 15 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.06891794 |
| 16 | Histidine metabolism_Homo sapiens_hsa00340 | 2.02536264 |
| 17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.01095044 |
| 18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.98756476 |
| 19 | Other glycan degradation_Homo sapiens_hsa00511 | 1.97453606 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 1.90917417 |
| 21 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.87424531 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.86037517 |
| 23 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.77512490 |
| 24 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.71745921 |
| 25 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.71416990 |
| 26 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.69645532 |
| 27 | Bile secretion_Homo sapiens_hsa04976 | 1.65936602 |
| 28 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.65789058 |
| 29 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.65657426 |
| 30 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.63738425 |
| 31 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.62839651 |
| 32 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.62420146 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.59890920 |
| 34 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.54695896 |
| 35 | ABC transporters_Homo sapiens_hsa02010 | 1.53363766 |
| 36 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.53170243 |
| 37 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.51628744 |
| 38 | Retinol metabolism_Homo sapiens_hsa00830 | 1.47011762 |
| 39 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.45151238 |
| 40 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.42515002 |
| 41 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.38846640 |
| 42 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.29414112 |
| 43 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.25226951 |
| 44 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.24869861 |
| 45 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.24666337 |
| 46 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.24102392 |
| 47 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.18761058 |
| 48 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.15403297 |
| 49 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.10452416 |
| 50 | Lysine degradation_Homo sapiens_hsa00310 | 1.05868790 |
| 51 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.02557527 |
| 52 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.02145438 |
| 53 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.01743803 |
| 54 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.95183425 |
| 55 | Carbon metabolism_Homo sapiens_hsa01200 | 0.93624437 |
| 56 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.90204676 |
| 57 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.89859738 |
| 58 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.88263564 |
| 59 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.81835367 |
| 60 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.81762565 |
| 61 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.81263222 |
| 62 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.78367771 |
| 63 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.78165871 |
| 64 | Sulfur relay system_Homo sapiens_hsa04122 | 0.74345492 |
| 65 | Pertussis_Homo sapiens_hsa05133 | 0.72593296 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.70934235 |
| 67 | Galactose metabolism_Homo sapiens_hsa00052 | 0.69968053 |
| 68 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.68360072 |
| 69 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.66694096 |
| 70 | Lysosome_Homo sapiens_hsa04142 | 0.65164543 |
| 71 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.64452951 |
| 72 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.63272824 |
| 73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.56438980 |
| 74 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.52581984 |
| 75 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.51072691 |
| 76 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.50880346 |
| 77 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.48489521 |
| 78 | Insulin resistance_Homo sapiens_hsa04931 | 0.48152462 |
| 79 | Focal adhesion_Homo sapiens_hsa04510 | 0.44656858 |
| 80 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.44374745 |
| 81 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.43936339 |
| 82 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.43863927 |
| 83 | Amoebiasis_Homo sapiens_hsa05146 | 0.43172013 |
| 84 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.42690456 |
| 85 | Mineral absorption_Homo sapiens_hsa04978 | 0.41309141 |
| 86 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.40488593 |
| 87 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.38577185 |
| 88 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.36963643 |
| 89 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.35766194 |
| 90 | Allograft rejection_Homo sapiens_hsa05330 | 0.35061590 |
| 91 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.33420566 |
| 92 | Metabolic pathways_Homo sapiens_hsa01100 | 0.32208640 |
| 93 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.30976062 |
| 94 | * Protein digestion and absorption_Homo sapiens_hsa04974 | 0.30159764 |
| 95 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.28389387 |
| 96 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.28378862 |
| 97 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.24799228 |
| 98 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.24628082 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.24376961 |
| 100 | Malaria_Homo sapiens_hsa05144 | 0.22136756 |
| 101 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.21703356 |
| 102 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.21010490 |
| 103 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.20683318 |
| 104 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.20592841 |
| 105 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.19389895 |
| 106 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.17982898 |
| 107 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.17021616 |
| 108 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.16798808 |
| 109 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.16176247 |
| 110 | Hepatitis C_Homo sapiens_hsa05160 | 0.16095836 |
| 111 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.13372264 |
| 112 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.12973182 |
| 113 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.12291632 |
| 114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.12058728 |
| 115 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.08607048 |
| 116 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.06638221 |
| 117 | Measles_Homo sapiens_hsa05162 | 0.06278324 |
| 118 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.04437246 |
| 119 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.04413047 |
| 120 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03534809 |
| 121 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.02806461 |
| 122 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.02228260 |
| 123 | Prion diseases_Homo sapiens_hsa05020 | 0.00959459 |
| 124 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.00670343 |
| 125 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.00589579 |
| 126 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.00159927 |
| 127 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0002741 |

